Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Cytomegalovirus Infection

  Free Subscription

Articles published in Antimicrob Agents Chemother

Retrieve available abstracts of 11 articles:
HTML format
Text format

Single Articles

    October 2018
  1. WANG Y, Mukhopadhyay R, Roy S, Kapoor A, et al
    Inhibition of Cytomegalovirus Replication with Extended Half-Life Synthetic Ozonides.
    Antimicrob Agents Chemother. 2018 Oct 29. pii: AAC.01735.
    PubMed     Text format     Abstract available

    June 2018
  2. CHOU S, Satterwhite LE, Ercolani RJ
    A New Locus of Drug Resistance in the Human Cytomegalovirus UL56 Gene Revealed by in vitro Exposure to Letermovir and Ganciclovir.
    Antimicrob Agents Chemother. 2018 Jun 18. pii: AAC.00922.
    PubMed     Text format     Abstract available

    April 2018
  3. OIKNINE-DJIAN E, Weisblum Y, Panet A, Wong HN, et al
    The Artemisinin Derivative Artemisone Is a Potent Inhibitor of Human Cytomegalovirus Replication.
    Antimicrob Agents Chemother. 2018 Apr 30. pii: AAC.00288.
    PubMed     Text format     Abstract available

    March 2018
  4. DONG Q, Leroux S, Shi HY, Xu HY, et al
    Model-based Dosage Individualization of Ganciclovir in Neonates and Young Infants with Congenital Cytomegalovirus Infection: A Pilot Study.
    Antimicrob Agents Chemother. 2018 Mar 5. pii: AAC.00075.
    PubMed     Text format     Abstract available

    November 2017
  5. DENG R, Wang Y, Maia M, Burgess T, et al
    Pharmacokinetics and exposure-response analysis of RG7667, a combination of two anti-cytomegalovirus monoclonal antibodies, in a Phase 2a randomized trial to prevent cytomegalovirus infection in high-risk kidney transplant recipients.
    Antimicrob Agents Chemother. 2017 Nov 13. pii: AAC.01108.
    PubMed     Text format     Abstract available

    October 2017
  6. MENG W, Tang A, Ye X, Gui X, et al
    Targeting Human Cytomegalovirus-Infected Cells by Redirecting T Cells Using an Anti-CD3/Anti-gB Bispecific Antibody.
    Antimicrob Agents Chemother. 2017 Oct 16. pii: AAC.01719.
    PubMed     Text format     Abstract available

    August 2017
  7. CHOU S
    Comparison of Cytomegalovirus Terminase Gene Mutations Selected after Exposure to Three Distinct Inhibitor Compounds.
    Antimicrob Agents Chemother. 2017 Aug 21. pii: AAC.01325.
    PubMed     Text format     Abstract available

  8. PIRET J, Goyette N, Boivin G
    Drug Susceptibility and Replicative Capacity of Multi-Drug Resistant Recombinant Human Cytomegalovirus Harboring Mutations in UL56 and UL54 Genes.
    Antimicrob Agents Chemother. 2017 Aug 14. pii: AAC.01044.
    PubMed     Text format     Abstract available

    November 2016
  9. ISHIDA JH, Patel A, Mehta AK, Gatault P, et al
    Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial of RG7667, a Combination Monoclonal Antibody, for Prevention of Cytomegalovirus Infection in High-Risk Kidney Transplant Recipients.
    Antimicrob Agents Chemother. 2016 Nov 21. pii: AAC.01794.
    PubMed     Text format     Abstract available

    April 2016
  10. PADULLES A, Colom H, Bestard O, Melilli E, et al
    Contribution of Population Pharmacokinetics to Dose Optimization of Ganciclovir-Valganciclovir in Solid-Organ Transplant Patients.
    Antimicrob Agents Chemother. 2016;60:1992-2002.
    PubMed     Text format     Abstract available

    November 2015
  11. VAZQUEZ JA, Manavathu EK
    Molecular Characterization of a Voriconazole-resistant, Posaconazole-susceptible, Aspergillus fumigatus Isolate in a Lung Transplant Recipient in the United States.
    Antimicrob Agents Chemother. 2015 Nov 16. pii: AAC.01130.
    PubMed     Text format     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Cytomegalovirus Infection is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.